Çalışma Alanları
- Sağlık Bilimleri Temel Alanı
- Tıbbi Onkoloji (İç Hastalıkları)
- Effectiveness and tolerability of FOLFIRINOX regime in metastatic pancreas cancer disease, 2018
- The prognostic significance of the18F‑fluorodeoxyglucose positron emissiontomography/computed tomography inearly‑stage nonsmall cell lung cancer, 2018
- Comparison of Somatostatin and Famotidine for the Treatment of Nonvariceal Acute Upper Gastrointestinal Bleeding, 2018
- Efficacy of Pemetrexed or Pemetrexed Plus Cisplatin/Carboplatin in Pretreated Patients with Advanced Non–Small-Cell Lung Cancer, 2018
- Rationale for Palliative Gastrectomy and Metastasectomy in Metastatic Gastric Cancer, 2018
- Predictive İmportance of Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio for Pathologic Complete Response in Locally Advanced Breast Cancer Patients ReceivingNeoadjuvant Chemotherapy, 2018
- Fulvestrant Efficacy in Artificial Menopausal Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer Patients under 50 Years Old, 2018
- Does tumor localization of operated NSCLC have an effect on relapse and survival?, 2018
- Folfiri plus panitumumab as the first-line treatment in patients with KRAS wild-type metastatic colorectal cencer. A single center experience., 2018
- FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer., 2018
- THE İMPACT OF RAMAZAN İ’TIKAF ON İMMUNE SYSTEM, 2017
- Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology), 2017
- Comparison of in-Hospital Cardiopulmonary Resuscitation Results Before and After the Introduction Code Blue, 2015
- Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer., 2015
- Biatrial Cardiac Metastases in a Patient with Uterine Cervix Malignant Melanoma., 2015
- Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer: a retrospective analysis of a multicentre study (Anatolian Society of Medical Oncology)., 2015
- Gastric Metastasis of Triple Negative Invasive Lobular Carcinoma., 2015
- Synchronous Pancreas Adenocarcinoma and Breast Infiltrative Ductal Carcinoma, 2014
- Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology)., 2014
- Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology., 2014
- Is lymph node ratio prognostic factor for survival in elderly patients with node positive breast cancer? The Anatolian Society of Medical Oncology., 2013
- Unusual region for pericardial malignant mesothelioma: cutaneous manifestation in a Turkish woman., 2013
- Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology., 2013
- Endocrine therapy alone vs. chemotherapy plus endocrine therapies for the treatment of elderly patients with endocrine-responsive and node positive breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology)., 2013
- Efficacy and Safety of Erlotinib in Previously Treated Advanced Non-Small Cell Lung Cancer, 2013
- Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology)., 2012
- Gemcitabine alone versus combination of gemcitabine and cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a retrospective analysis of multicenter study., 2012
- Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study, 2012
- Mesane Kanseri, 2011
- METASTATİK PANKREAS KANSERLİ TÜRK HASTALARDA FOLFİRİNOX REJİMİNİN ETKİNLİK VE TOLERABİLİTESİ.,
- EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab, 2017
- SAFRA YOLLARI KANSERİNDE CİSPLATİN VE GEMSİTABİN KOMBİNASYONU.(ATOD ÇALIŞMASI), 2012
- What are the differences between young (≤25 years) and adults (25 years) colorectal cancer (CRC), 2015
- HORMON POZİTİF METASTATİK MEME KANSERİ TEDAVİSİNDE FULVESTRANT ETKİNLİK VE TOLERABİLİTESİ. TEK MERKEZ DENEYİMİ., 2018
- METASTATİK MEME KANSERLİ HASTALARDA ERİBULİN TEDAVİSİNİN ETKİNLİĞİ (ATOD ÇALIŞMASI, 2015
- METASTATİK KOLOREKTAL KANSER TEDAVİSİNDE EGFR HEDEFLİ TEDAVİLER: PANİTUMUMAB DENEYİMİ. ETKİNLİK VE TOLERABİLİTE. ÇOK MERKEZLİ ATOD ÇALIŞMASI, 2015
- THE PROGNOSTİC ROLE OF XRCC1,ERCC1,ERCC2 AND TP53 SİGLE NUCLEOTİDE POLYMORPHİSMS(SNPs) İN NON SMALL CELL LUNG CANCER(NSCLC), 2013
- SYNCHRONOUS PANCREAS ADENOCARCİNOMA AND BREAST İNFİLTRATİVE DUCTAL CARCİNOMA, 2011
- GEMCİTABİNE ALONE VERSUS GEMCİTABİNE PLUS CİSPLATİN FOR THE TREATEMENT OF PATİENTS WİTH LOCALLY ADVANCED ANS/OR METASTATİC PANCREATİC ADENOCARCİNOMA: A RETROSPECTİVE ANALYSİS OF MULTİCENTER STUDY, 2011
- LAPATİNİB OR TRASTUZUMAB WHİCH ANTİ HER2 TREATEMENT İS MORE EFFECTİVE İN THE TREATEMENT OF PATİENTS WİTH HER2 POSİTİVE BREAST CANCER WİTH BRAİN METASTASES. AN ANATOLİAN SOCİETY OF MEDİCAL ONCOLOGY STUDY, 2012
- CHİLDHOOD, ADOLESCENTS AND YOUNG ADULTS (AGE 25 AND YOUNGER) COLORECTAL CANCER: A MULTİCENTER STUDY, 2011
- A RETROSPECTİVE EVALUATİON OF LOCALLY ADVANCED THYMOMA AND THYMİC CARCİNOMA: FACTORS İNFLUENCİNG THE PROGNOSİS AFTER LOCAL TREATEMENT MODALİTİES, 2013
- RELATİON OF METASTATİC STAGE AT THE DİAGNOSES OF NON-SMALL CELL LUNG CANCER (NSCLC) TO XRCC1 AND TP53 SİGLE NUCLEOTİDE POLYMORPHİSMS(SNPs), 2014
- Abiraterone acetate in patients with metastatic castration resistant prostate cencer(MCRPC) after dosetaxel chemotherapy: Multicenterexperience of Anatolian Society of Medical Oncology, 2014
- Is the microcalcification in mammography in patients diagnosed with breast cancer related to the bone metastasis and bad prognostic factors, 2010
- Efficacy and safety results of pemetrexed administration in non-small cell lung cancers, a multicenter study of the association of Anatolian Medical Oncology, 2013
- MİDE NÖROENDOKRİN KARSİNOMU İLE OVER GRANÜLOZA HÜCRELİ TÜMÖRÜN BİRLİKTE GÖRÜLDÜĞÜ BİR OLGU, 2011
- KALVARYUMDA KEMİK METASTAZI İLE TANI ALAN HEPATOSELÜLER KARSİNOM OLGUSU, 2011
- DİL YASSI HÜCRELİ KARSİNOMU,KOLON KARSİNOMU, GASTROİNTESTİNAL STROMAL TÜMÖR.KOİNSİDENTAL ÜÇ PRİMERLİ MALİGNANT OLGU SUNUMU, 2011
- BEYİN METASTAZI GELİŞEN MEME KANSERLİ HASTALARDA SİSTEMİK TEDAVİNİN BİOLOJİK ALT TİPLERE GÖRE SAĞKALIMA KATKISI(ATOD ÇALIŞMASI), 2012
- İLERİ YAŞTAKİ MEME KANSERLİ VAKALAR.TÜMÖR KAREKTERİSTİKLERİ(ATOD ÇALIŞMASI), 2012
- metastatik kolorektal kanserli hastalarda KRAS mutasyonu sıklığı ve kurtarma tedavisinde cetuximab kombinasyonlu tedavilerin etkinlik ve toksisitesinin retrospektif olarak değerlendirilmesi.güncel veriler(ATOD çalışması), 2012
- 70 YAŞ ÜSTÜ LENF NODU POZİTİF MEME KANSERLİ HASTALARDA ENDOKRİN TEDAVİ İLE ENDOKRİNKEMOTERAPİ TEDAVİSİNİN ETKİNLİĞİNİN KARŞILAŞTIRILMASI, 2012
- AİLESEL KOLON KANSERİ VAKALARIMIZ.ATOD ÇALIŞMASI, 2014
- ÇOCUK,ADELOSAN VE GENÇ ERİŞKİN (25 YAŞ) KOLOREKTAL KANSERLİ VAKALARIMIZ(ATOD ÇALIŞMASI), 2014
- METASTATİK MEME KANSERİNDE BEYİN METASTAZLARININ ERKEN VEYA GEÇ SAPTANMASININ VE DİĞER PROGNOSTİK FAKTÖRLERİN SAĞ KALIMA ETKİSİ VAR MI?, 2014
- SİSPLATİN VE ORLA ETOPOSİD METASTATİK MEME KANSERLİ VEYA BEYİN METASTAZLI HASTALARDA DİĞER KEMOTERAPÖTİKLER KADAR ETKİLİ BİR KOMBİNASYONMUDUR, 2014
- KHDAK tanılı hastalarda EGFR mutasyon sıklığının sağkalım ve diğer klinik-patolojik özelliklerle ilişkisi, çok merkezli ATOD çalışması., 2014
- Metastatik meme kanserinde metastazların sayı ve boyutunun ve diğer prognostik faktörlerin sağkalıma etkileri, 2013
- HER2 pozitif metastatik meme kanseri hastalarında beyin metastazı sonrası anti-HER2 tedavi stratejileri ve klinik sonuçları, 2012
- Küçük hücreli dışı akciğer kanserli hastalarda beyin metastazı sonrası kemoterapi alan 693 hastada sağ kalıma etki eden prognostik faktörlerin retrospektif olarak değerlendirilmesi(ATOD çalışması), 2014
- Lokal ileri veya metastatik pankreas kanserinde gemsitabin ile gemsitabin cisplatin kombinasyonu etkinliğinin ve toksisitesinin retrospektif olarak değerlendirilmesi, 2011
- ARE MİCROCALCİFİCATİON İN MAMMOGRAPHY İN PATİENTS DİAGNOSED WİTH BREAST CANCER RELATED WİTH THE BONE METASTASİS AND BAD PROCNOSTİC FACTORS, 2010
- KÜÇÜK HÜCRE DIŞI AKCİĞER KANSERİNDE PEMETREXED UYGULAMASININ ETKİNLİK VE GÜVENİLLİLİK SONUÇLARI. ÇOK MERKEZLİ ATOD ÇALIŞMASI., 2012
- METASTATİK MEME KANSERLİ DAHA ÖNCEDEN ANTRASİKLİN VE TAKSAN KULLANMIŞ OLAN HASTALARDA İV SİSPLATİN VE ORAL ETOPOSİT ETKİNLİĞİ, 2013
- Metastatik kolorektal kanserli hastalarda salvage tedavide cetuximab irinotekan kombinasyon tedavisinin etkinlik ve tolerabilitesinin retrospektif olarak değerlendirilmesi. ATOD çalışması., 2011
- OPERE ERKEN EVRE KOLON KANSERİNDE VUCUT KİTLE İNDEKSİNİN NÜKS LOKALİZASYONU, HASTALIKSIZ SAĞKALIM VE GENEL SAĞKALIMA ETKİSİ., 2018
- The prevalance of BRCA1/BRCA2 mutations among before age 60 women with triple negative breast cancer Single center experiance., 2017
- 40 Yaş Altı Meme Kanserli Türk Hastalarda BRCA1 ve BRCA2 Gen Mutasyon Oranları.Tek Merkez Deneyimi., 2017
- ERKEN EVRE KÜÇÜK HÜCRE DIŞI AKCİĞER PET-CT 18 FDG SUV MAX DEĞERİNİN PROGNOSTİK ÖNEMİ, 2016
- Tıbbi Onkoloji Araştırma Birincilik Ödülü, 2016
